Probiotics: definition, sources, selection, and uses
- PMID: 18181724
- DOI: 10.1086/523341
Probiotics: definition, sources, selection, and uses
Abstract
Interest in probiotics is at an all-time high in the United States, driven in part by new products emerging in the market, by US researchers eager to evaluate efficacy claims rigorously, and by consumers interested in potential therapeutic and preventive health benefits. The US marketplace is a mixed bag of products, some well-defined and properly evaluated in controlled clinical studies and others with unsubstantiated claims of efficacy. Validation of probiotic contents in commercial products is needed to ensure consumer confidence. The term "probiotic" should be used only for products that meet the scientific criteria for this term-namely, products that contain an adequate dose of live microbes that have been documented in target-host studies to confer a health benefit. Probiotics must be identified to the level of strain, must be characterized for the specific health target, and must be formulated into products using strains and doses shown to be efficacious. Several characteristics commonly presumed to be essential to probiotics, such as human origin and the ability to improve the balance of the intestinal microbiota, are discussed.
Similar articles
-
Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S76-9; discussion S144-51. doi: 10.1086/523337. Clin Infect Dis. 2008. PMID: 18181728
-
Current marketplace for probiotics: a Japanese perspective.Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S73-5; discussion S144-51. doi: 10.1086/523338. Clin Infect Dis. 2008. PMID: 18181727
-
Probiotics in the United States.Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339. Clin Infect Dis. 2008. PMID: 18181726 Review.
-
Probiotics--the friendly bacteria with market potential in global market.Pak J Pharm Sci. 2007 Jan;20(1):76-82. Pak J Pharm Sci. 2007. PMID: 17337434 Review.
-
Development of consumer probiotics for the US market.Br J Nutr. 1998 Oct;80(4):S213-8. Br J Nutr. 1998. PMID: 9924287
Cited by
-
Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial.PLoS One. 2012;7(9):e43910. doi: 10.1371/journal.pone.0043910. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970150 Free PMC article. Clinical Trial.
-
Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials.Nutrients. 2020 Jan 1;12(1):124. doi: 10.3390/nu12010124. Nutrients. 2020. PMID: 31906372 Free PMC article.
-
Role of intestinal microbiota and metabolites in inflammatory bowel disease.Chin Med J (Engl). 2019 Jul 5;132(13):1610-1614. doi: 10.1097/CM9.0000000000000290. Chin Med J (Engl). 2019. PMID: 31090547 Free PMC article. Review.
-
Plant-Derived Lactobacillus paracasei IJH-SONE68 Improves Chronic Allergy Status: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Nutrients. 2021 Nov 11;13(11):4022. doi: 10.3390/nu13114022. Nutrients. 2021. PMID: 34836277 Free PMC article. Clinical Trial.
-
Lactobacillus reuteri attenuates cardiac injury without lowering cholesterol in low-density lipoprotein receptor-deficient mice fed standard chow.Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H32-H41. doi: 10.1152/ajpheart.00569.2019. Epub 2020 May 15. Am J Physiol Heart Circ Physiol. 2020. PMID: 32412785 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources